Inactivation of bradykinin by angiotensin-converting enzyme and by carboxypeptidase N in human plasma.
about
Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type 1 diabetes.Circulating proteolytic products of carboxypeptidase N for early detection of breast cancerFine-tune regulation of carboxypeptidase N1 controls vascular patterning during zebrafish development.Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitusInvestigation and reduction of sub-microgram peptide loss using molecular weight cut-off fractionation prior to mass spectrometric analysis.Role of bradykinin in preconditioning and protection of the ischaemic myocardium.Carboxypeptidase B and other kininases of the rat coronary and mesenteric arterial bed perfusates.Increased tissue angiotensin-converting enzyme activity impairs bradykinin-induced dilation of coronary arterioles in obesityBradykinin and angiotensin-converting enzyme inhibition in cardioprotection.Soluble gC1qR is an autocrine signal that induces B1R expression on endothelial cells.The bradykinin-cGMP-PKG pathway augments insulin sensitivity via upregulation of MAPK phosphatase-5 and inhibition of JNK.Whole-genome sequencing study of serum peptide levels: the Atherosclerosis Risk in Communities study.Angiotensin converting enzyme inhibition reduces cardiovascular responses to acute stress in myocardially infarcted and chronically stressed rats.Role of bradykinin in angiotensin-converting enzyme knockout mice.Dysregulation of the Renin-Angiotensin System and the Vasopressinergic System Interactions in Cardiovascular Disorders.Neprilysin Inhibitors and Bradykinin
P2860
Q31112191-85B0C125-440D-4200-AD02-5D842007752CQ33685829-46911164-3028-40E1-A7B9-5839EBEC0393Q33687095-956A1161-71A4-4A78-B12F-B466A273EE9BQ33897901-EF657D83-3BC8-4EDC-9C7F-20346EDABD7EQ34423522-BA36E331-F625-4965-A201-A47D320FB359Q34542200-AB0D4515-4201-4EC0-B248-D7DF39ECC957Q34695673-3801D42F-04FA-4BCC-BB83-63B35CB69EEDQ36965013-F558D8ED-1F73-459B-90E6-98CAD5DCA5CCQ37276516-669E4570-FEB3-441D-87E2-80BEB828B4DCQ37423077-FDE30654-6145-43EF-9CF9-942F98D1C2D0Q38692385-BB384C0A-1931-458B-B21A-A44C8DBBC6E9Q40064772-F6FC59EB-BF64-4825-AA8A-049025877FD8Q42725776-E585EB30-FBA8-45B2-8812-8267B438AEC0Q54784257-A22F768B-6689-48BF-ACF1-52557D50D8FBQ55153307-14870F35-E708-47BE-A281-303A4C401A10Q57072764-808C9A57-E0A5-4385-B72C-0A5A6F4E4141
P2860
Inactivation of bradykinin by angiotensin-converting enzyme and by carboxypeptidase N in human plasma.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Inactivation of bradykinin by ...... xypeptidase N in human plasma.
@ast
Inactivation of bradykinin by ...... xypeptidase N in human plasma.
@en
type
label
Inactivation of bradykinin by ...... xypeptidase N in human plasma.
@ast
Inactivation of bradykinin by ...... xypeptidase N in human plasma.
@en
prefLabel
Inactivation of bradykinin by ...... xypeptidase N in human plasma.
@ast
Inactivation of bradykinin by ...... xypeptidase N in human plasma.
@en
P2093
P2860
P1476
Inactivation of bradykinin by ...... xypeptidase N in human plasma.
@en
P2093
Kokkonen JO
Kovanen PT
Kuoppala A
Lindstedt KA
Saarinen J
P2860
P304
P356
10.1152/AJPHEART.2000.278.4.H1069
P577
2000-04-01T00:00:00Z